A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy
Clinical trial NCT05861986 · RECRUITING
Trial details
- NCT number
- NCT05861986
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-30
- Primary completion
- 2028-03-31
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.